📰 Stride Velocity News
Stride Velocity News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stride Velocity. Real-time updates on events, politics, business and more.
May 20, 2024
- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months - - DYNE-101 Showed Improvement in Myotonia,...
May 20, 2024
- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months - ...
August 26, 2023
EMA opinion marks the first Qualification of a digital outcome measure for use as a Primary Endpoint in pivotal drug trials SV95C is an objective, real-world ...
August 8, 2023
/PRNewswire/ -- SYSNAV Healthcare announces that the European Medicines Agency (EMA) considers that for ambulant Duchenne Muscular Dystrophy (DMD) patients...
April 27, 2023
Current methods for assessing ambulatory function in patients with Duchenne muscular dystrophy do not fully reflect how they experience DMD in their...